Molecular characterization of an EWSR1-POU5F1 fusion associated with a t(6;22) in an undifferentiated soft tissue sarcoma

被引:18
|
作者
Deng, Fang-Ming [1 ]
Galvan, Karen [2 ]
de la Roza, Gustavo [1 ]
Zhang, Shengle [1 ]
Souid, Abdul-Kader [3 ]
Stein, Constance K. [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY USA
[2] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY USA
[3] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA
关键词
Chromosome; 22; chromosome; 6; EWSR1; POU5F1; soft tissue sarcoma; EWSR1; DIFFERENTIATION; EXPRESSION; CARCINOMA; BIOLOGY; MARKER; POU5F1; FAMILY; CELLS; TUMOR;
D O I
10.1016/j.cancergen.2011.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a soft tissue sarcoma from the thigh with morphologic features resembling Ewing sarcoma, clear cell sarcoma, and myoepithelial tumor of soft tissue. In addition, the genetic and immunohistochemical findings do not correspond to any established pattern, so the tumor does not clearly fit into any one classification. The karyotype analysis revealed a rare chromosomal rearrangement, t(6;22)(p22;q12), that previously has been reported in bone and epithelial tumors. Molecular studies confirmed the presence of an EWSR1-POU5F1 fusion creating a chimeric gene with the N-terminal transcriptional activation domain of EWSR1 and the C-terminal POU DNA binding domain of POU5F1. This report is novel in that to our knowledge, it is the first complete molecular characterization of an EWSR1 POU5F1 fusion in a soft tissue sarcoma. Evaluation of existing data on the known EWSR1 POU5F1 tumors suggests that the fusion gene functions in a wide variety of cell types and may modify the differentiation state of cells, resulting in susceptibility to tumorigenesis.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [41] RUNX1-PDCD6 fusion resulting from a novel t(5;21)( p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia
    Panagopoulos, Iannis
    Gorunova, Ludmila
    Jacobsen, Eva-Marie
    Andersen, Kristin
    Micci, Francesca
    Heim, Sverre
    PLOS ONE, 2018, 13 (04):
  • [42] MOLECULAR CYTOGENETIC CHARACTERIZATION OF T(2;5)(P16.2;Q33.1) LEADING TO PDGFRB/SPTBN1 GENE FUSION IN A CASE OF MDS RESPONSIVE TO IMATINIB MESYLATE
    Koumbi, D.
    Psyllaki, M.
    Pappa, V.
    Zachaki, S.
    Daraki, A.
    Manola, K.
    Parcharidou, A.
    Pantelias, G.
    Sambani, C.
    HAEMATOLOGICA, 2014, 99 : 86 - 87
  • [43] Cationic cyclopentadienyl phenylenediamido titanium species generated by reaction of TiCpR[1,2-C6H4(NCH2t-Bu)2]R (CpR = η5-C5H5, η5-C5Me5; R = CH3, CH2Ph) with B(C6F5)3. -: X-ray -: Molecular structure of Ti(η5-C5Me5)[1,2-C6H4(NCH2t-Bu)2][μ-MeB(C6F5)3]
    Tabernero, V
    Maestre, C
    Jiménez, G
    Cuenca, T
    de Arellano, CR
    ORGANOMETALLICS, 2006, 25 (07) : 1723 - 1727
  • [44] Three Novel AML Cases Harboring the Semi-Cryptic t(7;21)(p22;q22) Translocation Expressing RUNX1-USP42 Fusion Transcripts Associated with Diploidy/Tetraploidy and/or 5q Alterations: a Probably Underestimated Combination
    Jeandidier, Eric
    Gervais, Carine
    Radford-Weiss, Isabelle
    Gangneux, Catherine
    Rimelen, Valerie
    Jung, Georges
    Harzallah, Ines
    Drenou, Bernard
    Lioure, Bruno
    Mauvieux, Laurent
    BLOOD, 2010, 116 (21) : 1116 - 1116
  • [45] Rearrangement of the COL12A1 and COL4A5 genes in subungual exostosis:: molecular cytogenetic delineation of the tumor-specific translocation t(X;6)(q13-14;q22)
    Storlazzi, CT
    Wozniak, A
    Panagopoulos, I
    Sciot, R
    Mandahl, N
    Mertens, F
    Debiec-Rychter, M
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (08) : 1972 - 1976
  • [46] 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript:: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality
    Park, Tae Sung
    Song, Jaewoo
    Kim, Jin Seok
    Yang, Woo Ick
    Song, Sungwook
    Kim, Sue Jung
    Suh, Borum
    Choi, Jong Rak
    CANCER GENETICS AND CYTOGENETICS, 2008, 181 (02) : 93 - 99
  • [47] Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia
    Crescenzi, Barbara
    La Starza, Roberta
    Nozzoli, Chiara
    Ciolli, Stefania
    Matteucci, Caterina
    Romoli, Silvia
    Rigacci, Luigi
    Gorello, Paolo
    Bosi, Alberto
    Martelli, Massimo F.
    Marynen, Peter
    Mecucci, Cristina
    CANCER GENETICS AND CYTOGENETICS, 2007, 176 (01) : 67 - 71
  • [48] 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormailty (vol 181, pg 93, 2008)
    Park, T. S.
    Song, J.
    Kim, J. S.
    Yang, W.
    Song, S.
    Kim, S. J.
    Suh, B.
    Choi, J. R.
    CANCER GENETICS AND CYTOGENETICS, 2008, 183 (01) : 82 - 82
  • [49] Molecular characterization of erythromycin-resistant clinical isolates of the four major antimicrobial-resistant Spanish clones of Streptococcus pneumoniae (Spain23F-1, Spain6B-2, Spain9V-3, and Spain14-5)
    Marimón, JM
    Iglesias, L
    Vicente, D
    Pérez-Trallero, E
    MICROBIAL DRUG RESISTANCE, 2003, 9 (02) : 133 - 137
  • [50] Synthesis and characterization of platinum(II)-bis(boryl) catalyst precursors for diboration of alkynes and diynes: Molecular structures of cis-[(PPh(3))(2)Pt(B-4-Bu(t)cat)(2)], cis-[(PPh(3))(2)Pt(Bcat)(2)], cis-[(dppe)Pt(Bcat)(2)], cis-[(dppb)Pt(Bcat)(2)], (E)-(4-MeOC(6)H(4))C(Bcat)=CH(Bcat), (Z)-(C6H5)C(Bcat)=C(C6H5)(Bcat), and (Z,Z)-(4-MeOC(6)H(4))C(Bcat)=C(Bcat)C(Bcat)=C(4-MeOC(6)H(4))(Bcat) (cat equals 1,2-O2C6H4; dppe equals Ph(2)PCH(2)CH(2)PPh(2); dppb equals Ph(2)P(CH2)(4)PPh(2))
    Lesley, G
    Nguyen, P
    Taylor, NJ
    Marder, TB
    Scott, AJ
    Clegg, W
    Norman, NC
    ORGANOMETALLICS, 1996, 15 (24) : 5137 - 5154